activity
20172021
most citedA causal approach to analysis of censored medical costs in the presence of time-varying treatment

1 citations · 1 across the 6 of their papers we have counts for

collaborators
Showing stat.MEShow all

8 papers · 1 filter

stat.ME2021

Combining Real-World and Randomized Control Trial Data Using Data-Adaptive Weighting via the On-Trial Score

Joanna Harton, Brian Segal, Ronac Mamtani +2

Clinical trials with a hybrid control arm (a control arm constructed from a combination of randomized patients and real-world data on patients receiving usual care in standard clin…

stat.ME2021

Identifying optimally cost-effective dynamic treatment regimes with a Q-learning approach

Nicholas Illenberger, Andrew J. Spieker, Nandita Mitra

Health policy decisions regarding patient treatment strategies require consideration of both treatment effectiveness and cost. Optimizing treatment rules with respect to effectiven…

stat.ME2021

A regression framework for a probabilistic measure of cost-effectiveness

Nicholas Illenberger, Nandita Mitra, Andrew J. Spieker

To make informed health policy decisions regarding a treatment, we must consider both its cost and its clinical effectiveness. In past work, we introduced the net benefit separatio…

stat.ME2020

Doubly Robust Nonparametric Instrumental Variable Estimators for Survival Outcomes

Youjin Lee, Edward H. Kennedy, Nandita Mitra

Instrumental variable (IV) methods allow us the opportunity to address unmeasured confounding in causal inference. However, most IV methods are only applicable to discrete or conti…

stat.ME2020

Bayesian Nonparametric Cost-Effectiveness Analyses: Causal Estimation and Adaptive Subgroup Discovery

Arman Oganisian, Nandita Mitra, Jason Roy

Cost-effectiveness analyses (CEAs) are at the center of health economic decision making. While these analyses help policy analysts and economists determine coverage, inform policy,…

stat.ME2019

Net benefit separation and the determination curve: a probabilistic framework for cost-effectiveness estimation

Andrew J. Spieker, Nicholas Illenberger, Jason A. Roy +1

Considerations regarding clinical effectiveness and cost are essential in comparing the overall value of two treatments. There has been growing interest in methodology to integrate…